Tenax Therapeutics Inc.

NASDAQ: TENX · Real-Time Price · USD
5.90
-0.05 (-0.84%)
At close: Aug 15, 2025, 3:59 PM
6.09
3.22%
After-hours: Aug 15, 2025, 05:30 PM EDT

Tenax Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-31.48M -24.21M -17.6M -14.56M -12.57M -10.1M -7.71M -7.03M -7.98M -9.73M -11.05M -11.71M -12.59M -11.45M -32.47M -32.09M -30.52M -30.94M
Depreciation & Amortization
n/a n/a n/a 4.71K 5.67K 6.67K 7.57K 32.07K 59.61K 86.62K 113.33K 110.96K 108.71K 106.37K 108.98K 111.64K 114.26K 117.02K
Stock-Based Compensation
9.88M 5.27M 1.13M -12.15 24.86 2.80 -115.99 37.01 n/a n/a n/a n/a n/a n/a n/a n/a 63.16 126.33
Other Working Capital
1.49M 918.22K 918.35K 28.89K -29.7K -707.59K -707.12K 160.11K 188.17K -234.68K -79.59K -223.68K 61.23K 490.8K -443.15K 131.82K -854.29K -1.32M
Other Non-Cash Items
-135K -103.78K 22.86K 218.78K 243.14K 268.06K 216.18K 258.89K 300.68K 356.15K 367.05K 500.9K 789.65K 525.92K 22.12M 21.98M 21.7M 21.94M
Deferred Income Tax
n/a n/a n/a -37.01 -74.02 -124.31 -124.31 -87.3 -136.87 -196.62 -196.62 -196.62 -110.03 n/a n/a n/a n/a n/a
Change in Working Capital
1.9M 2.44M 1.64M 1.88M 870.96K 483.9K 1.58M -299.11K -673.54K -1.51M -1.45M -1.37M -465.35K 242.72K -610.09K -77.49K -737.67K -938K
Operating Cash Flow
-19.84M -16.61M -14.81M -12.46M -11.45M -9.34M -5.9M -7.04M -8.29M -10.8M -12.01M -12.47M -12.16M -10.57M -10.86M -10.08M -9.44M -9.82M
Capital Expenditures
3.00 3.00 3.00 1.6K 1.61K 1.61K 2.85K 5.25K 5.24K 5.24K -2.32K -8.02K -9.7K -11.57K -5.25K -7.04K -5.37K -3.49K
Cash Acquisitions
n/a n/a n/a -2.84K -2.84K -2.84K -2.84K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -118.39K -345.54K -483.63K -590.93K -677.37K
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 513.22K 613.22K 803.4K 948.48K 545.26K 670.34K
Other Investing Acitivies
n/a n/a n/a 1.24K 1.24K 2.84K 2.84K 1.6K 1.6K n/a n/a 1.88K 1.88K 1.88K 1.88K n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a 1.6K 2.84K 6.84K 6.84K 5.24K -2.32K -8.02K 503.52K 483.25K 452.61K 457.81K -51.03K -10.53K
Debt Repayment
-278.9K -413.27K -501K -675.37K -567.85K -601.64K -624.3K 174.47K 253.87K 285.14K 624.3K n/a 91.88K 228.76K n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a -14.19K -14.47K -14.47K -14.47K -8.21K -15.86K -15.86K -15.86K -7.93K n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
340.74K 340.74K 1.83M 1.84M 1.78M 1.78M 525.5K 513.37K 230.73K 230.73K 2.06K 8.42M 8.42M 8.42M 8.96M 544.65K 544.65K 2.48M
Financial Cash Flow
115.92M 115.51M 99.87M 99.63M 7.44M 7.48M 13.57M 14.37M 14.45M 22.34M 8.55M 7.93M 17.21M 9.42M 9.74M 9.74M 7.08M 9.01M
Net Cash Flow
96.08M 98.9M 85.06M 87.17M -4.01M -1.87M 7.67M 7.33M 6.16M 11.55M -3.46M -4.55M 5.56M -668.1K -666.32K 118.54K -2.41M -821.89K
Free Cash Flow
-19.84M -16.61M -14.81M -12.46M -11.45M -9.34M -5.9M -7.04M -8.29M -10.8M -12.02M -12.48M -12.17M -10.58M -10.86M -10.08M -9.44M -9.83M